Elixira
Elixira is a manufacturer and supplier of lozenges and food supplements, offering sugar-free, medicated, and natural flavors with worldwide delivery.
Classification
Profile
Funding
Funding details not yet available.
Offers 28+ sugar-free, medicated, and natural lozenge flavors with worldwide delivery, leveraging GIDA's manufacturing expertise.
Health-conscious individuals, patients needing medicated lozenges, and consumers seeking natural/sugar-free alternatives.
Direct retail sales of lozenges and food supplements via global e-commerce and partnerships.
Direct-to-consumer online platform with global shipping, supplemented by B2B partnerships for distribution.
GIDA INTERNATIONAL GROUP for manufacturing, distribution, and food supplement R&D.
Production costs for lozenges, global logistics, and R&D for flavor/medication formulations.
GIDA's manufacturing infrastructure, 28+ proprietary lozenge formulas, and international delivery network.
Product formulation R&D, quality assurance of lozenges, and global supply chain management.
Customer acquisition via targeted health/medication marketing, retention through product quality and loyalty incentives.
Competes with niche supplement brands by offering a broader flavor range and direct global delivery.
Limited access to diverse, high-quality lozenge options; unreliable international delivery for health products.
- Obtain and display third-party certifications (EU Organic, Vegan Society, ISO-22000). Visible badges on the site will reduce purchase hes
Audit current certifications and prioritize ISO-22000 or GMP audit within 90 days · Design a subscription landing page with tiered pricing and integrate with Shopify’s recurring billing API · Identify 5 micro-influencers (10k-50k followers) in the vegan/health niche; negotiate 3-month trial campaigns with UGC content
The direct-to-consumer channel enables global reach, which is only viable due to GIDA's established international delivery network and manufacturing infrastructure.
- Regulatory foothold: The company’s Turkish base and reference to GIDA International Group suggest access to GMP-compliant facilities, a s
No investors recorded yet.